basal cell carcinoma skin cancer
Conditions
Interventions
In one group, 3 mm skin biopsies will be performed, this is the conventionale
regular diagnostic method which is invasive.
In the other group, in vivo reflectance microscopy will be performed, this i
Sponsors
Radboud Universitair Medisch Centrum
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: - Age *18 years - Patient must be able to adhere to all requirements of the study - Patient must be willing to give written informed consent - Clinically diagnosed/ clinical suspicion of basal cell carcinoma
Exclusion criteria
Exclusion criteria: - Participating in other investigational research currently or in the previous 28 days before the study - Patient is having a medical condition which excludes participating the research, according to the investigator - Incapacitated subjects will not be included - Lesion(s) on parts of the body which do not allow to adequately image the tumour with RCM.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary Objective: To study whether in vivo reflectance confocal microscopy (RCM) can correctly identify the subtype of BCC. Primary outcome measure is defined as: - Correct sub-typing of BCC after excision. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome measures: - QoL - Cost - QALY's - The ability of RCM to separate sBCC from other BCCs - Development of guidelines and protocols for future RCM users. | — |
Countries
Netherlands
Outcome results
None listed